Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma
Affiliations: Cancer Research Center, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, P.R. China, Department of Pathology, Xuchang Central Hospital, Affiliated to Henan University of Science and Technology, Xuchang, Henan 461000, P.R. China, Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA, Basic Research Program, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA
- Published online on: March 26, 2021 https://doi.org/10.3892/or.2021.8029
- Article Number: 78
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.